My watch list
my.bionity.com  
Login  

595 Current news about the topic life sciences

rss

You can refine your search further. Select from the filter options on the left to narrow down your results.

Merck Launches Seed Fund for Startups in China

RMB 100 million fund targets startups close to the three business sectors of Merck as well as new businesses

21-Oct-2019

Merck announced an RMB 100 million (€ 13 million) seed fund targeted at startups in China. The company also officially opened its innovation hub in Shanghai and announced plans to officially open a second innovation hub in Guangzhou in November. “Our RMB 100 million China seed fund underlines our ...

more

image description
German Accelerator Appoints Marc Filerman as CEO Life Sciences

20-Jun-2019

German Accelerator announces the appointment of Marc Filerman as Chief Executive Officer of the Life Science program. Mr. Filerman is a highly experienced healthcare entrepreneur and venture consultant with a proven track record of launching and managing medical device, and diagnostic companies. ...

more

image description
Merck Opens Application Phase for Next Accelerator

Startups can apply for programs at Merck headquarters in Darmstadt or in China

07-Jun-2019

Merck announced that it has opened the next round of applications for startup companies to participate in the global Merck Accelerator program. Startups can choose to participate in one of the two programs, either at the company’s Innovation Center at global headquarters in Darmstadt or at its ...

more

image description
For Start-ups and Founders: Inauguration of DESY Innovation Village

The new DESY Innovation Village is the place for start-ups and innovative projects at DESY

26-Feb-2019

“I Love Innovation” was the fitting motto with which the DESY Innovation Village was officially inaugurated on Valentine’s Day, in the presence of DESY’s Board of Directors and representatives of the federal and local Hamburg governments. It will offer DESY start-ups offices, workshops and ...

more

Scailyte raises CHF 2.75M in seed funding

Investments from Swisscom Ventures & Zürcher Kantonalbank

29-Jan-2019

Scailyte AG, a Swiss startup in the emerging and rapidly growing field of single-cell technologies, raised CHF 2.75Min seed fundingand gained Swisscom Ventures as a strategic investor. Zürcher Kantonalbank also joined the financing round, alongside the existing shareholders, thus reaffirming ...

more

Merck Paves the Way for its Innovation Hub in Southern China

Company signed agreement with Guangzhou Development District

12-Nov-2018

Merck signed an agreement with the Guangzhou Development District on innovation development in Southern China. Pursuant to this agreement, Merck will establish an innovation hub in Guangzhou scheduled to open September 2019. “China is a major innovation hotspot and one of our most important ...

more

Merck Ignites Firework of Research Initiatives During its 350th Anniversary Year

Funding of up to € 350,000 per research grant or up to € 30,000 per research challenge

23-May-2018

Merck announced several research grants and challenges during the company’s 350th anniversary year in addition to already existing initiatives. The new research grants and challenges are mainly directed to scientists working in institutes, universities or start-up companies around the world. “The ...

more

Danaher to acquire Integrated DNA Technologies

12-Mar-2018

Danaher Corporation and Integrated DNA Technologies announced that Danaher has entered into a definitive agreement to acquire IDT, a privately-held provider of high-value consumables for genomics applications in molecular biology, qPCR, next generation sequencing, synthetic biology, gene editing ...

more

SYGNIS completes integration of acquired companies under new brand

08-Mar-2018

SYGNIS AG announced its subsidiaries Innova Biosciences, Expedeon Holdings, and C.B.S. Scientific have united as Expedeon, effective 1 March 2018. The corporate rebranding follows the latest acquisition of Innova Biosciences by SYGNIS AG in June 2017. SYGNIS AG will continue to serve as the ...

more

Merck and Three Partners Start ExploreBio

Also announces CRISPR-patent allowances in Israel and South Korea

21-Feb-2018

Merck announced ExploreBio, a pre-seed-investment vehicle by four investment funds targeted at early-stage companies in the biotechnology landscape in Israel. For this purpose the strategic corporate venture capital arm of Merck has partnered with Arkin Holdings, Pontifax and WuXi AppTec to ...

more

Page 1 From 60
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE